WEST PHARMACEUTICAL SERVICES DANMARK ApS: Financial statements 2022
CVR: 16210714
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
WEST PHARMACEUTICAL SERVICES DANMARK ApS (CVR 16210714) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 793,333,000 and a net result of DKK 31,744,000 compared with DKK 27,442,000 the year before. That is an increase of 11.1% compared with the year before. The profit margin was 4%. Equity in the 2022 report amounted to DKK 994,198,000. The solvency ratio was 51.1%. The company had 241 employees in the financial year.
- Revenue
- DKK 793,333,000
- Gross Profit
- DKK 150,395,000
- Profit/Loss
- DKK 31,744,000
- Equity
- DKK 994,198,000
- Total Assets
- DKK 1,946,531,000
- Employees
- 241
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 793.3 mio. | 150.4 mio. | 31.7 mio. | 994.2 mio. | 241 |
| 2021 | 713.9 mio. | 122.2 mio. | 27.4 mio. | 887.5 mio. | 228 |
| 2020 | 618.4 mio. | 118.6 mio. | 24.6 mio. | 860 mio. | 223 |
| 2019 | 595.2 mio. | 113 mio. | 37.6 mio. | 835.4 mio. | 227 |
| 2018 | 579.7 mio. | 144.5 mio. | 371.2 mio. | 404 mio. | 227 |
Official annual report
Keep an eye on WEST PHARMACEUTICAL SERVICES DANMARK ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
WEST PHARMACEUTICAL SERVICES DANMARK ApS has published its annual report for 2021. Revenue came to DKK 713,943,000, and the net result was DKK 27,442,000.
About WEST PHARMACEUTICAL SERVICES DANMARK ApS
WEST PHARMACEUTICAL SERVICES DANMARK ApS is a Danish company of the type Anpartsselskab based in Horsens, founded in 1999. The company is registered under the industry Fremstilling af letmetalemballage. The company was previously named WEST PHARMACEUTICAL SERVICES DANMARK A/S and THE WEST COMPANY, DANMARK A/S. The management consists of Peter Thorup Hovgaard. The board consists of Shay Kearns (chair), Charlotte Monfeldt Horsbøll, John Ditlev Larsen and Peter Thorup Hovgaard. The company is owned by West Pharmaceutical Services of Delaware, Inc.. The company has 364 employees (2026). In 2025, the company reported revenue of DKK 1,336,445,000 and a net result of DKK 66,980,000 compared with DKK 11,749,681,000 the year before. Equity in the 2025 report amounted to DKK 265,128,000.